Market Overview:
The global home use CGM system market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, growing awareness about diabetes and its complications, and technological advancements in CGM systems. Based on type, the global home use CGM system market can be segmented into retrospective CGM and real-time monitoring. The real-time monitoring segment is expected to grow at a higher rate than the retrospective monitoring segment during the forecast period. This growth can be attributed to the increasing demand for real-time monitoring systems as they provide more accurate information about blood sugar levels than retrospective systems do. Based on application, the global home use CGMSystem market can be divided into elderly patients, adult patients, and pediatric patients. The pediatric patient segment is expected to grow at a higher rate than other segments duringthe forecast period owingto rising incidence of childhood obesityand diabetes mellitusin developed countries such as USto name few .
Product Definition:
A home use CGM system is a device that helps people with diabetes to monitor their blood glucose levels. The device sends real-time information about the person's blood sugar level to a computer or mobile app, which can help them make decisions about their diabetes care. Home use CGM systems are important because they provide people with diabetes with accurate information about their blood sugar levels, which can help them manage their disease more effectively.
Retrospective CGM:
Retrospective CGM is a method of measuring the glucose level in patients using continuous glucose monitoring (CGMS) devices. It is also known as real-time CGM or time-sensitized CGM. The major factor driving this market includes growing prevalence of diabetes and rising demand for self-monitoring devices, which are used by people with diabetes to measure blood sugar levels.
Real-Time Monitoring:
Real-time monitoring is the continuous glucose monitoring system that provides results for blood sugar. It measures glucose level in patient's blood as it flows through a sensor. The real-time monitor displays results on its screen and also gives audible alerts when needed.
Application Insights:
The application segment is sub-divided into elderly, adults and pediatric. The elderly held the largest share of over 40% in 2017. This is due to the increasing geriatric population worldwide that suffers from various diseases related to CVDs and diabetes which can be treated with a home use CGMS.
Adults are expected to be the fastest growing segment owing to rising awareness about advanced medical care coupled with technological advancements in glucose monitoring devices. For instance, Medtronic launched a new Continuous Glucose Monitoring System - MiniMed Insulin Pump Withings Smart Scale iBGStar Pro by 2019 which wirelessly connects to an insulin pump for accurate dosing adjustment based on user's body weight.
Regional Analysis:
North America dominated the global home use CGM system market in 2017. This can be attributed to favorable reimbursement policies, technological advancements, and increasing healthcare expenditure in this region. The Centers for Medicare & Medicaid Services (CMS), which is an agency of the U.S. Department of Health and Human Services has included the product with its list of reasonable medical devices that are not subject to any additional payment under section 1342(b)(1) of the Act if they are used solely at home for a patient's own diagnosis or treatment purposes without any commercial benefit involved other than personal gain by a provider or supplier (11).
Growth Factors:
- Increasing prevalence of diabetes and other chronic diseases: The global prevalence of diabetes is expected to increase from 9% in 2014 to 10.4% by 2030. This will create a larger patient population that is in need of glucose monitoring devices, including home use CGM systems.
- Advances in technology and decreasing costs: Home use CGM systems are becoming increasingly sophisticated, with smaller sensors and longer battery life times. Additionally, the cost of these devices is dropping, making them more affordable for patients.
- Growing awareness among patients and healthcare professionals: There is growing awareness among both patients and healthcare professionals about the benefits of using home use CGM systems for managing blood sugar levels. This will help to drive demand for these devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Home Use CGM System Market Research Report
By Type
Retrospective CGM, Real-Time Monitoring
By Application
Elderly, Adults, Pediatric
By Companies
Abbott Laboratories, Dexcom, Inc., Medtronic plc, Insulet Corp., F. Hoffmann-La Roche AG, Ascensia Diabetes Care Holdings AG, AgaMatrix, Inc., Integrity Applications, Inc., Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment, San Meditech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
216
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Home Use CGM System Market Report Segments:
The global Home Use CGM System market is segmented on the basis of:
Types
Retrospective CGM, Real-Time Monitoring
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Elderly, Adults, Pediatric
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Dexcom, Inc.
- Medtronic plc
- Insulet Corp.
- F. Hoffmann-La Roche AG
- Ascensia Diabetes Care Holdings AG
- AgaMatrix, Inc.
- Integrity Applications, Inc.
- Senseonics Holdings
- GlySens Incorporated
- Meiqi Medical Equipment
- San Meditech
Highlights of The Home Use CGM System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Retrospective CGM
- Real-Time Monitoring
- By Application:
- Elderly
- Adults
- Pediatric
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Home Use CGM System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Home Use CGM System is a type of diabetes device that helps people with diabetes monitor their blood sugar levels at home. This system typically includes a sensor, an accompanying computer or phone app, and a delivery system (such as an insulin pump). The sensor attaches to the person's skin and sends data about the person's blood sugar levels to the app. The app then uses this information to provide real-time updates about the person's blood sugar level.
Some of the major companies in the home use cgm system market are Abbott Laboratories, Dexcom, Inc., Medtronic plc, Insulet Corp., F. Hoffmann-La Roche AG, Ascensia Diabetes Care Holdings AG, AgaMatrix, Inc., Integrity Applications, Inc., Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment, San Meditech.
The home use cgm system market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Home Use CGM System Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Home Use CGM System Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Home Use CGM System Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Home Use CGM System Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Home Use CGM System Market Size & Forecast, 2018-2028
4.5.1 Home Use CGM System Market Size and Y-o-Y Growth
4.5.2 Home Use CGM System Market Absolute $ Opportunity
Chapter 5 Global Home Use CGM System Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Home Use CGM System Market Size Forecast by Type
5.2.1 Retrospective CGM
5.2.2 Real-Time Monitoring
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Home Use CGM System Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Home Use CGM System Market Size Forecast by Applications
6.2.1 Elderly
6.2.2 Adults
6.2.3 Pediatric
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Home Use CGM System Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Home Use CGM System Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Home Use CGM System Analysis and Forecast
9.1 Introduction
9.2 North America Home Use CGM System Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Home Use CGM System Market Size Forecast by Type
9.6.1 Retrospective CGM
9.6.2 Real-Time Monitoring
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Home Use CGM System Market Size Forecast by Applications
9.10.1 Elderly
9.10.2 Adults
9.10.3 Pediatric
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Home Use CGM System Analysis and Forecast
10.1 Introduction
10.2 Europe Home Use CGM System Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Home Use CGM System Market Size Forecast by Type
10.6.1 Retrospective CGM
10.6.2 Real-Time Monitoring
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Home Use CGM System Market Size Forecast by Applications
10.10.1 Elderly
10.10.2 Adults
10.10.3 Pediatric
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Home Use CGM System Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Home Use CGM System Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Home Use CGM System Market Size Forecast by Type
11.6.1 Retrospective CGM
11.6.2 Real-Time Monitoring
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Home Use CGM System Market Size Forecast by Applications
11.10.1 Elderly
11.10.2 Adults
11.10.3 Pediatric
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Home Use CGM System Analysis and Forecast
12.1 Introduction
12.2 Latin America Home Use CGM System Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Home Use CGM System Market Size Forecast by Type
12.6.1 Retrospective CGM
12.6.2 Real-Time Monitoring
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Home Use CGM System Market Size Forecast by Applications
12.10.1 Elderly
12.10.2 Adults
12.10.3 Pediatric
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Home Use CGM System Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Home Use CGM System Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Home Use CGM System Market Size Forecast by Type
13.6.1 Retrospective CGM
13.6.2 Real-Time Monitoring
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Home Use CGM System Market Size Forecast by Applications
13.10.1 Elderly
13.10.2 Adults
13.10.3 Pediatric
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Home Use CGM System Market: Competitive Dashboard
14.2 Global Home Use CGM System Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Dexcom, Inc.
14.3.3 Medtronic plc
14.3.4 Insulet Corp.
14.3.5 F. Hoffmann-La Roche AG
14.3.6 Ascensia Diabetes Care Holdings AG
14.3.7 AgaMatrix, Inc.
14.3.8 Integrity Applications, Inc.
14.3.9 Senseonics Holdings
14.3.10 GlySens Incorporated
14.3.11 Meiqi Medical Equipment
14.3.12 San Meditech
